Literature DB >> 17153463

Role of selective arterial secretin injection test in treatment of gastrinoma.

Chikashi Shibata1, Yuji Funayama, Kouhei Fukushima, Ken-Ichi Takahashi, Tatsuya Ueno, Munenori Nagao, Sho Haneda, Kazuhiro Watanabe, Katsuyoshi Kudoh, Atsushi Kohyama, Hiroo Naito, Iwao Sasaki.   

Abstract

BACKGROUND/AIMS: To study whether use of the selective arterial secretin injection test increased the rate of tumor localization and curative resection in patients with gastrinoma.
METHODOLOGY: Nine patients with gastrinoma were divided into 2 groups, before and after introduction of selective arterial secretin injection test; 4 patients before 1987 (Group 1) and 5 patients after 1988 (Group 2). Clinical results were compared retrospectively between groups.
RESULTS: Localization of primary gastrinoma was made with conventional imaging studies in 1 of the 4 patients in Group 1 and 3 of the 5 patients in Group 2. In contrast, use of the selective arterial secretin injection test was able to localize the primary tumor in 4 of the 5 patients in Group 2. Total gastrectomy was carried out in the 4 patients in Group 1, and pancreatoduodenectomy was the most frequently performed procedure (3 patients) in Group 2. Rate of curative resection was 25% and 80% in Groups 1 and 2, respectively.
CONCLUSIONS: These results indicate that combining selective arterial secretin injection test with conventional imaging studies contributes to increasing rate of curative resection of gastrinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17153463

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Criteria for the glucagon provocative test in the diagnosis of gastrinoma.

Authors:  Chikashi Shibata; Masayuki Kakyo; Makoto Kinouchi; Naoki Tanaka; Koh Miura; Takeshi Naitoh; Hitoshi Ogawa; Fuyuhiko Motoi; Shinichi Egawa; Tatsuya Ueno; Hiroo Naito; Michiaki Unno
Journal:  Surg Today       Date:  2012-09-16       Impact factor: 2.549

2.  The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.

Authors:  Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Tatsuya Ueno; Atsushi Kohyama; Kennichi Satoh; Tooru Shimosegawa; Tetsuya Yamagiwa; Iwao Sasaki
Journal:  J Gastrointest Surg       Date:  2007-10-11       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.